Alimuddin Zumla Selected Research

Alimuddin Zumla Research Topics

Disease

90	Tuberculosis (Tuberculoses) 02/2024 - 10/2003
37	Infections 10/2023 - 03/2005
37	COVID-19 04/2023 - 01/2020
16	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 11/2022 - 05/2010
14	Communicable Diseases (Infectious Diseases) 01/2023 - 04/2009
12	Pulmonary Tuberculosis 03/2017 - 10/2002
11	Extensively Drug-Resistant Tuberculosis 11/2022 - 09/2010
9	Respiratory Tract Infections (Respiratory Tract Infection) 11/2022 - 05/2013
8	Neoplasms (Cancer) 01/2020 - 10/2015
6	Latent Tuberculosis 03/2019 - 07/2004
5	Inflammation (Inflammations) 12/2022 - 05/2012
5	Noncommunicable Diseases 01/2019 - 05/2012
4	Latent Infection 01/2018 - 06/2004
4	HIV Infections (HIV Infection) 10/2015 - 07/2008
3	Coinfection 04/2023 - 10/2005
3	Reinfection 12/2021 - 01/2021
3	Severe Acute Respiratory Syndrome 12/2021 - 11/2014
3	Malaria 01/2020 - 03/2017
3	Virus Diseases (Viral Diseases) 12/2019 - 10/2015
3	Acquired Immunodeficiency Syndrome (AIDS) 12/2018 - 04/2002
3	Human Influenza (Influenza) 05/2016 - 11/2014
2	Dengue (Dengue Fever) 01/2024 - 01/2021
2	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 03/2017
2	Viremia 07/2019 - 01/2018
2	Lung Injury 01/2018 - 04/2016
2	Persistent Infection 03/2017 - 10/2012
2	Necrosis 03/2015 - 01/2011
2	Cough 05/2012 - 10/2005
1	Acidosis 01/2023
1	Critical Illness (Critically Ill) 01/2023
1	Ebola Hemorrhagic Fever 01/2023
1	Bacterial Infections (Bacterial Infection) 01/2023
1	Mpox (monkeypox) 01/2023
1	Myocarditis (Carditis) 12/2022
1	Myocardial Infarction 12/2022
1	Cardiac Arrhythmias (Arrythmia) 12/2022

Drug/Important Bio-Agent (IBA)

31	VaccinesIBA 06/2023 - 08/2005
21	Biomarkers (Surrogate Marker)IBA 01/2023 - 03/2009
20	AntigensIBA 07/2022 - 08/2005
12	Rifampin (Rifampicin)FDA LinkGeneric 02/2024 - 09/2010
12	Anti-Bacterial Agents (Antibiotics)IBA 04/2023 - 05/2010
12	CytokinesIBA 04/2021 - 05/2004
8	Messenger RNA (mRNA)IBA 01/2024 - 07/2004
8	Interferon-gamma (Interferon, gamma)IBA 03/2019 - 07/2004
7	RNA (Ribonucleic Acid)IBA 01/2023 - 07/2004
7	Isoniazid (Ftivazide)FDA LinkGeneric 11/2022 - 09/2010
7	Interleukin-4 (Interleukin 4)IBA 01/2011 - 06/2004
5	AntibodiesIBA 01/2023 - 03/2017
5	bedaquiline (R207910)IBA 01/2023 - 01/2017
5	Antiviral Agents (Antivirals)IBA 07/2020 - 11/2014
5	EpitopesIBA 03/2017 - 01/2013
4	OPC-67683IBA 11/2022 - 01/2015
4	AerosolsIBA 01/2020 - 10/2005
4	InterferonsIBA 01/2020 - 10/2005
4	DNA (Deoxyribonucleic Acid)IBA 11/2018 - 03/2002
4	Nucleic AcidsIBA 10/2015 - 01/2009
4	InterleukinsIBA 03/2015 - 08/2004
3	BCG Vaccine FDA Link 01/2023 - 05/2012
3	FluoroquinolonesIBA 11/2022 - 03/2015
3	Proteins (Proteins, Gene)FDA Link 12/2021 - 03/2017
3	Interleukin-6 (Interleukin 6)IBA 04/2021 - 10/2020
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2020 - 01/2020
3	Virulence Factors (Pathogenicity Factors)IBA 01/2020 - 06/2004
3	Tuberculin (PPD)IBA 03/2019 - 02/2010
3	Monoclonal AntibodiesIBA 03/2017 - 04/2016
3	Ethambutol (Myambutol)FDA LinkGeneric 03/2017 - 09/2010
3	Pyrazinamide FDA LinkGeneric 03/2017 - 09/2010
3	Peptides (Polypeptides)IBA 03/2017 - 01/2013
3	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 05/2016 - 01/2016
3	lipoarabinomannan (LAM)IBA 09/2015 - 01/2009
2	3- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA 10/2023 - 01/2023
2	AcidsIBA 01/2023 - 03/2017
2	IgYIBA 01/2023 - 01/2022
2	Immunoglobulin M (IgM)IBA 01/2023 - 01/2020
2	Immunoglobulin G (IgG)IBA 01/2023 - 01/2020
2	Angiotensin-Converting Enzyme 2IBA 12/2022 - 04/2021
2	Linezolid (Zyvox)FDA Link 11/2022 - 12/2012
2	Interleukin-8 (Interleukin 8)IBA 04/2021 - 10/2020
2	Immunomodulating AgentsIBA 06/2016 - 04/2016
2	Imipenem FDA Link 05/2016 - 01/2016
2	Meropenem (Merrem)FDA LinkGeneric 04/2016 - 01/2016
2	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2015 - 03/2015
2	EnzymesIBA 03/2015 - 11/2005
2	Moxifloxacin (Avelox)FDA Link 03/2015 - 05/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2013 - 03/2005
2	Drug CombinationsIBA 05/2012 - 05/2012
1	insulin receptor-related receptor (IRR)IBA 01/2024
1	16S Ribosomal RNAIBA 01/2024
1	Acetic Acid (Vinegar)FDA LinkGeneric 01/2024
1	LactamsIBA 04/2023
1	POD-IIIBA 01/2023
1	InflammasomesIBA 01/2023

Therapy/Procedure

51	Therapeutics 01/2022 - 02/2009
9	Immunotherapy 01/2023 - 10/2002
8	Duration of Therapy 04/2018 - 01/2012
4	Drug Therapy (Chemotherapy) 11/2022 - 10/2003
3	Highly Active Antiretroviral Therapy (HAART) 12/2018 - 05/2010
2	Critical Care (Surgical Intensive Care) 06/2022 - 10/2020
2	Art Therapy 07/2015 - 07/2014
1	Topical Administration 01/2023